Béatrice Bouvard, Erick Legrand. Use of adjuvant bone resorption inhibitors in breast cancer. Revue du Rhumatisme, 2026, 93 (4), pp.609-615. ⟨10.1016/j.rhum.2026.01.029⟩. ⟨hal-05737016⟩
Accès au bibtex
ref_biblio
Béatrice Bouvard. Oncology in rheumatology: From bone metastases to skeletal fragility. Revue du Rhumatisme, 2026, 93 (4), pp.582-583. ⟨10.1016/j.rhum.2026.04.004⟩. ⟨hal-05737189⟩
Accès au bibtex
ref_biblio
Béatrice Bouvard. Rheumatology and oncology: Clinical and therapeutic interactions. Revue du Rhumatisme, 2026, 93 (3), pp.404-405. ⟨10.1016/j.rhum.2026.04.001⟩. ⟨hal-05737176⟩
Accès au bibtex
ref_biblio
Lucie Danet, Romain Guiho, Sally Hussein, Anaïs Defois, Nicolas Gaigeard, et al.. Multimodal analysis of osteoarthritic chondrocytes reveals mitochondrial alterations and patient-specific OxPhos response to bezafibrate. 2026. ⟨hal-05599166⟩
Accès au texte intégral et bibtex
ref_biblio
Morgane Mermet, Quentin Massiquot, Nadine Gaborit, Stéphanie Lemiere, Jean-Daniel Kün-Darbois, et al.. Chondrocyte proliferation without inflammation underlies botulinum toxin–induced mandibular enthesis bone hypertrophy in rats. Biochemical and Biophysical Research Communications, 2026, 813, pp.153608. ⟨10.1016/j.bbrc.2026.153608⟩. ⟨hal-05721766⟩
Accès au texte intégral et bibtex
ref_biblio
Lucie Levaillant, Guillaume Mabilleau, Adèle Malagié, Sixtine Donat, Régis Coutant, et al.. Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis. Osteoporosis International, 2026, ⟨10.1007/s00198-026-07918-6⟩. ⟨hal-05740411⟩
Accès au bibtex
ref_biblio
Cyrille B. Confavreux, Béatrice Bouvard, Nicolas Girard, Pauline Bosco-Levy, Clarisse Marchal, et al.. Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study. Journal of Bone Oncology, 2026, 56, pp.100738-100738. ⟨10.1016/j.jbo.2025.100738⟩. ⟨hal-05502874⟩
Accès au texte intégral et bibtex
ref_biblio
Morgane Mermet, Jessica Denom, Aleksandra Mieczkowska, Méline Wery, Emma Biggs, et al.. The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice. AJP - Endocrinology and Metabolism, 2026, 329 (4), pp.E522 - E536. ⟨10.1152/ajpendo.00086.2025⟩. ⟨hal-05722182⟩
Accès au texte intégral et bibtex
ref_biblio
Agnes Ostertag, Bastien Léger, Eugenie Koumakis, Patrice Fardellone, Mylene Zarka, et al.. Impaired organic and mineral extracellular matrix composition in early-onset osteoporosis. Journal of Bone and Mineral Research, 2025, ⟨10.1093/jbmr/zjaf159⟩. ⟨hal-05354516⟩
Accès au bibtex
ref_biblio
Léa Karam, Guillaume Mabilleau, Julien Paccou. Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity. Osteoporosis International, 2025, ⟨10.1007/s00198-025-07664-1⟩. ⟨hal-05323285⟩
